Cargando…
The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
BACKGROUND: The elevation of the platelet-to-lymphocyte ratio (PLR), an easily applicable blood test based on platelet and lymphocyte counts has been associated with poor prognosis in patients with different types of cancer. The present study was aimed to investigate the prognostic significance of t...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021515/ https://www.ncbi.nlm.nih.gov/pubmed/24675383 http://dx.doi.org/10.1038/bjc.2014.163 |
_version_ | 1782316250070777856 |
---|---|
author | Krenn-Pilko, S Langsenlehner, U Thurner, E-M Stojakovic, T Pichler, M Gerger, A Kapp, K S Langsenlehner, T |
author_facet | Krenn-Pilko, S Langsenlehner, U Thurner, E-M Stojakovic, T Pichler, M Gerger, A Kapp, K S Langsenlehner, T |
author_sort | Krenn-Pilko, S |
collection | PubMed |
description | BACKGROUND: The elevation of the platelet-to-lymphocyte ratio (PLR), an easily applicable blood test based on platelet and lymphocyte counts has been associated with poor prognosis in patients with different types of cancer. The present study was aimed to investigate the prognostic significance of the preoperative PLR in a large cohort of breast cancer patients. METHODS: Data from 793 consecutive non-metastatic breast cancer patients, treated between 1999 and 2004, were evaluated retrospectively. The optimal cutoff values for the PLR were calculated using receiver operating curve analysis. Cancer-specific survival (CSS), overall survival (OS) as well as distant metastasis-free survival (DMFS) were assessed using the Kaplan–Meier method. To evaluate the independent prognostic significance of PLR, multivariable Cox regression models were applied for all three different end points. RESULTS: Univariable analysis revealed a significant association between the elevated preoperative PLR and CSS (hazard ratio (HR): 2.75, 95% confidence interval (CI): 1.57–4.83, P<0.001) that remained statistically significant in multivariable analysis (HR: 2.03, 95% CI: 1.03–4.02, P=0.042). An increased PLR was also significantly associated with decreased OS in univariable (HR: 2.45, 95% CI: 1.43–4.20, P=0.001) and in multivariable analysis (HR: 1.92, 95% CI: 1.01–3.67, P=0.047). Furthermore, univariable analysis showed a significant impact of increased PLR on DMFS (HR: 2.02, 95% CI: 1.18–3.44, P=0.010). Subgroup analysis revealed significant associations of the elevated PLR on the primary end point CSS for all breast cancer subtypes. This association retained its significance in multivariable analysis in patients with luminal B tumours (HR: 2.538, 95% CI: 1.043–6.177, P=0.040). CONCLUSIONS: In this study, we identified the preoperative PLR as an independent prognostic marker for survival in breast cancer patients. Independent validation of our findings is needed. |
format | Online Article Text |
id | pubmed-4021515 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-40215152015-05-13 The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients Krenn-Pilko, S Langsenlehner, U Thurner, E-M Stojakovic, T Pichler, M Gerger, A Kapp, K S Langsenlehner, T Br J Cancer Molecular Diagnostics BACKGROUND: The elevation of the platelet-to-lymphocyte ratio (PLR), an easily applicable blood test based on platelet and lymphocyte counts has been associated with poor prognosis in patients with different types of cancer. The present study was aimed to investigate the prognostic significance of the preoperative PLR in a large cohort of breast cancer patients. METHODS: Data from 793 consecutive non-metastatic breast cancer patients, treated between 1999 and 2004, were evaluated retrospectively. The optimal cutoff values for the PLR were calculated using receiver operating curve analysis. Cancer-specific survival (CSS), overall survival (OS) as well as distant metastasis-free survival (DMFS) were assessed using the Kaplan–Meier method. To evaluate the independent prognostic significance of PLR, multivariable Cox regression models were applied for all three different end points. RESULTS: Univariable analysis revealed a significant association between the elevated preoperative PLR and CSS (hazard ratio (HR): 2.75, 95% confidence interval (CI): 1.57–4.83, P<0.001) that remained statistically significant in multivariable analysis (HR: 2.03, 95% CI: 1.03–4.02, P=0.042). An increased PLR was also significantly associated with decreased OS in univariable (HR: 2.45, 95% CI: 1.43–4.20, P=0.001) and in multivariable analysis (HR: 1.92, 95% CI: 1.01–3.67, P=0.047). Furthermore, univariable analysis showed a significant impact of increased PLR on DMFS (HR: 2.02, 95% CI: 1.18–3.44, P=0.010). Subgroup analysis revealed significant associations of the elevated PLR on the primary end point CSS for all breast cancer subtypes. This association retained its significance in multivariable analysis in patients with luminal B tumours (HR: 2.538, 95% CI: 1.043–6.177, P=0.040). CONCLUSIONS: In this study, we identified the preoperative PLR as an independent prognostic marker for survival in breast cancer patients. Independent validation of our findings is needed. Nature Publishing Group 2014-05-13 2014-03-27 /pmc/articles/PMC4021515/ /pubmed/24675383 http://dx.doi.org/10.1038/bjc.2014.163 Text en Copyright © 2014 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
spellingShingle | Molecular Diagnostics Krenn-Pilko, S Langsenlehner, U Thurner, E-M Stojakovic, T Pichler, M Gerger, A Kapp, K S Langsenlehner, T The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients |
title | The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients |
title_full | The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients |
title_fullStr | The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients |
title_full_unstemmed | The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients |
title_short | The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients |
title_sort | elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients |
topic | Molecular Diagnostics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021515/ https://www.ncbi.nlm.nih.gov/pubmed/24675383 http://dx.doi.org/10.1038/bjc.2014.163 |
work_keys_str_mv | AT krennpilkos theelevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients AT langsenlehneru theelevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients AT thurnerem theelevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients AT stojakovict theelevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients AT pichlerm theelevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients AT gergera theelevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients AT kappks theelevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients AT langsenlehnert theelevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients AT krennpilkos elevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients AT langsenlehneru elevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients AT thurnerem elevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients AT stojakovict elevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients AT pichlerm elevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients AT gergera elevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients AT kappks elevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients AT langsenlehnert elevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients |